共 50 条
Reasons for Treatment Changes in Patients With Moderate to Severe Psoriasis
被引:5
|作者:
Anderson, Kathryn L.
[1
]
Feldman, Steven R.
[1
,2
,3
]
机构:
[1] Wake Forest Sch Med, Dept Dermatol, Ctr Dermatol Res, Winston Salem, NC 27157 USA
[2] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC 27157 USA
[3] Wake Forest Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA
关键词:
psoriasis;
phototherapy;
dermatology;
TREATMENT PATTERNS;
DRUG SURVIVAL;
BIOLOGICS;
DISCONTINUATION;
POPULATION;
ETANERCEPT;
ADALIMUMAB;
CARE;
IMPAIRMENT;
THERAPIES;
D O I:
10.1177/1203475415572797
中图分类号:
R75 [皮肤病学与性病学];
学科分类号:
100206 ;
摘要:
Background: Psoriasis treatment involves multiple treatment arms. Treatment choice depends on many factors and may change, due to the chronicity of psoriasis. Objective: The purpose of our study is to explore reasons for treatment changes in patients with moderate to severe psoriasis. Methods: Ten charts of patients with moderate to severe psoriasis were reviewed. The medication changes and reasons for change were extracted. A treatment change was defined as switching between medication classes, adding or removing a medication class, or switching medications within the oral or biologic medication class. Results: Seventy-seven treatment changes were identified. On average, I treatment change occurred per year of follow-up. The most common reason for treatment change was inadequate disease control. Conclusions: Inadequate disease control with current therapy is the most common reason a physician changes treatment for moderate to severe psoriasis. More efficacious treatments or ways to improve efficacy may help improve the long-term outcomes of psoriasis.
引用
收藏
页码:361 / 366
页数:6
相关论文